Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk : a meta-analysis
The matrix metalloproteinases (MMP) can degrade various components of the extracellular matrix and its functional genetic polymorphisms may be associated with breast cancer risk. However, this relationship remains controversial. A meta-analysis was conducted in order to investigate the potential association between four polymorphisms in the MMP gene and breast cancer risk. A database search yielded a total of 9 studies involving 2,597 cases and 2,618 controls. Four polymorphisms were included in the meta-analysis: MMP-1 -1607 2G/1G (rs1799750), MMP-2 -1306 C/T (rs243865), MMP-3 -1171 6A/5A (rs3025058) and MMP-9 -1562 C/T (rs3918242). Crude odds ratios (OR) with 95% confidence intervals (CI) were used to assess the strength of association. When all the studies were pooled into the meta-analysis, we found that breast cancer cases had a significantly higher frequency of CC genotype (OR = 1.27, 95% CI = 1.10, 1.47; P = 0.001) and lower frequency of CT genotype (OR = 0.78, 95% CI = 0.67, 0.91; P = 0.001) of MMP-2. No significant difference was found in any genotype of MMP-1, MMP-3 or MMP-9. In conclusion, this meta-analysis suggested that MMP-2 -1306 C/T polymorphism may contribute to breast cancer susceptibility. More studies were needed especially in Asians in the future.
| Errataetall: |
CommentIn: Breast Cancer Res Treat. 2011 Jul;128(2):589-91. - PMID 21336947 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2011 |
|---|---|
| Erschienen: |
2011 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:127 |
|---|---|
| Enthalten in: |
Breast cancer research and treatment - 127(2011), 3 vom: 21. Juni, Seite 813-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhou, Ping [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 3.4.24.- |
|---|
| Anmerkungen: |
Date Completed 22.11.2011 Date Revised 08.04.2022 published: Print-Electronic CommentIn: Breast Cancer Res Treat. 2011 Jul;128(2):589-91. - PMID 21336947 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10549-010-1294-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM20438317X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM20438317X | ||
| 003 | DE-627 | ||
| 005 | 20231223231927.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231223s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10549-010-1294-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0681.xml |
| 035 | |a (DE-627)NLM20438317X | ||
| 035 | |a (NLM)21161369 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Ping |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk |b a meta-analysis |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.11.2011 | ||
| 500 | |a Date Revised 08.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Breast Cancer Res Treat. 2011 Jul;128(2):589-91. - PMID 21336947 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The matrix metalloproteinases (MMP) can degrade various components of the extracellular matrix and its functional genetic polymorphisms may be associated with breast cancer risk. However, this relationship remains controversial. A meta-analysis was conducted in order to investigate the potential association between four polymorphisms in the MMP gene and breast cancer risk. A database search yielded a total of 9 studies involving 2,597 cases and 2,618 controls. Four polymorphisms were included in the meta-analysis: MMP-1 -1607 2G/1G (rs1799750), MMP-2 -1306 C/T (rs243865), MMP-3 -1171 6A/5A (rs3025058) and MMP-9 -1562 C/T (rs3918242). Crude odds ratios (OR) with 95% confidence intervals (CI) were used to assess the strength of association. When all the studies were pooled into the meta-analysis, we found that breast cancer cases had a significantly higher frequency of CC genotype (OR = 1.27, 95% CI = 1.10, 1.47; P = 0.001) and lower frequency of CT genotype (OR = 0.78, 95% CI = 0.67, 0.91; P = 0.001) of MMP-2. No significant difference was found in any genotype of MMP-1, MMP-3 or MMP-9. In conclusion, this meta-analysis suggested that MMP-2 -1306 C/T polymorphism may contribute to breast cancer susceptibility. More studies were needed especially in Asians in the future | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 7 | |a Matrix Metalloproteinases |2 NLM | |
| 650 | 7 | |a EC 3.4.24.- |2 NLM | |
| 700 | 1 | |a Du, Liang-Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Lv, Guo-Qiang |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Xian-Ming |e verfasserin |4 aut | |
| 700 | 1 | |a Gu, Yuan-Long |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Jian-Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Chun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breast cancer research and treatment |d 1992 |g 127(2011), 3 vom: 21. Juni, Seite 813-8 |w (DE-627)NLM01302132X |x 1573-7217 |7 nnns |
| 773 | 1 | 8 | |g volume:127 |g year:2011 |g number:3 |g day:21 |g month:06 |g pages:813-8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10549-010-1294-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 127 |j 2011 |e 3 |b 21 |c 06 |h 813-8 | ||